Company Profile

Smart Quotes

NATCO PHARMA LTD.

NSE : NATCOPHARMBSE : 524816ISIN CODE : INE987B01026Industry : Pharmaceuticals & DrugsHouse : Natco

BSE813.555.3 (+0.66 %)

PREV CLOSE ( ) 808.25

OPEN PRICE ( ) 810.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 11462

TODAY'S LOW / HIGH ( )810.65 821.30

52 WK LOW / HIGH ( )660.05 1504

NSE813.554.55 (+0.56 %)

PREV CLOSE( ) 809.00

OPEN PRICE ( ) 810.00

BID PRICE (QTY) 813.55 (41)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 313756

TODAY'S LOW / HIGH( ) 810.00 821.75

52 WK LOW / HIGH ( )726.8 1505

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-09 1981

Management Info

V C Nannapaneni - Chairman V C Nannapaneni - Managing Director

Registered Office

Address Natco House,Road No 2,Banjara Hills,
Hyderabad,
Telangana-500034

Phone 040-23547532

Email investors@natcopharma.co.in / dasaradhi@natcopharma.co.in

Website www.natcopharma.co.in

Registrars Details

Venture Capital & Corporate Investments Ltd

Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57,4th & 5th Floors,Jayabheri Enclave Phase - II, Gachibowli,Hyderabad

Listing : BSE, NSE

NEWS

03Oct Natco Pharma informs about disclosure
Natco Pharma has informed that it enclosed disclosure under Regulation 2..

25Sep Natco Pharma gets nod to evaluate deme
Natco Pharma has received in-principle approval to evaluate the demerger..

25Sep Natco Pharma informs about outcome of
Natco Pharma has informed that the Board of Directors at their meeting h..

19Sep Natco Pharma informs about disclosure
Natco Pharma has informed that it enclosed disclosure under Regulation 2..

18Sep Natco Pharma’s Hyderabad division rece
Natco Pharma’s Hyderabad pharma division has received Establishment Insp..

Financials

in Millions

	QTR Jun 25	ANNUAL 25
Net Profit	4641	18504
Gross Profit	5429	22260
Operating Profit	5993	24656
Net Sales	11927	40945

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE) 15713.90 (1.51%)	M.Cap ( in Cr)20160.76
Pfizer (BSE) 5263.35 (1.50%)	M.Cap ( in Cr)24078.63
Strides Pharma Scien (BSE) 852.35 (6.95%)	M.Cap ( in Cr)7856.34
Lupin (BSE) 1957.45 (2.72%)	M.Cap ( in Cr)89408.07
Aurobindo Pharma (BSE) 1118.95 (4.59%)	M.Cap ( in Cr)64988.80

Shareholding Pattern

	PROMOTERS	49.56%
	NON-INSTITUTION	29.28%
	FI/BANKS/INSURANCE	3.43%
	MUTUAL FUNDS/UTI	2.11%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Tata Value Fund(G)	1.77
Tata Nifty MidSmall Healthcare Index Fund-Reg(G)	1.40
Motilal Oswal Nifty MidSmall Healthcare Index Fund-Reg(G)	1.40
Kotak Nifty Smallcap 50 Index Fund-Reg(G)	1.18
Aditya Birla SL Nifty Smallcap 50 Index Fund-Reg(G)	1.17
Axis Nifty Smallcap 50 Index Fund-Reg(G)	1.17
Baroda BNP Paribas Small Cap Fund-Reg(G)	1.05